These findings support a cellular ecosystem framework for understanding therapeutic response and resistance in inflammatory bowel disease and suggest that therapeutic efficacy may depend on the capacity to remodel multicellular communication networks rather than simply neutralizing individual molecular targets.
Although immune-targeted therapies, particularly agents targeting the IL-23/IL-17 axis, have markedly improved short-term disease control in psoriasis, inadequate responses in a subset of patients and relapse after treatment discontinuation remain unresolved challenges. One possible reason is that immune-centered thera...
Mei-Jun Liu, Pin-Zhi Dong, Cong Yang et al.· British Journal of Dermatolo...· 0 citations
Crohn’s disease and ulcerative colitis are now treated with an expanding set of biologics and small molecules, yet treatment selection remains largely empirical. Primary non-response, secondary loss of response, incomplete mucosal healing, fibrostenosis, and fistulizing disease show that conventional clinical, endoscop...
Hai Wang, Xiao-Long Zhao, Jie Yang· Frontiers in Immunology· 0 citations
While immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape for melanoma and lung cancer, their efficacy in prostate cancer (PCa) remains limited. This therapeutic resistance is linked in part to the "cold" immunophenotype of PCa, which is orchestrated by a highly immunosuppressive tumor micro...
Si-Yu Zhou, Yi-Fan Bi, Zi-Yi Xiong et al.· Critical reviews in oncology...· 0 citations
Tumor drug resistance is still the core obstacle limiting the long-term benefit of modern anticancer therapy, especially in the context of treatment tolerance, persistence of minimal residual disease (MRD) and recurrence after treatment. Increasing evidence has shown that therapy-associated myeloid niches can involve c...
Ting Li, Yan-Xia Lin, Q. Gang et al.· Cancer Letters· 0 citations
This review provides an integrated and conceptual analysis of the HCC immune landscape, delineating the mechanistic drivers underlying immune suppression, summarizes current immune-based classification frameworks, and dissects the context-dependent functions of key immune cell populations in tumor progression.
Jia-Qian Zhang, Si-Wen Li, Xiang-Long Ma et al.· Cancer Biology and Medicine· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.